Impact of fetal-maternal tolerance in hematopoietic stem cell transplantation

Archivum Immunologiae et Therapiae Experimentalis

Volumn 54, Issue 3, 2006, Pages 165-172

  Teshima, Takanori ^a   Matsuoka, Ken Ichi ^b   Ichinohe, Tatsuo ^c  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

GVHD; HSCT; Non inherited maternal antigen

Indexed keywords

ANTIGEN; NON INHERITED MATERNAL ANTIGEN; UNCLASSIFIED DRUG;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CLINICAL STUDY; EXPERIMENTAL TRANSPLANTATION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; IMMUNOLOGICAL TOLERANCE; MICROCHIMERISM; MORBIDITY; MORTALITY; MOTHER FETUS RELATIONSHIP; NONHUMAN; PREGNANCY; PUERPERIUM; REVIEW; TREATMENT OUTCOME;

ANIMALS; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; MATERNAL-FETAL EXCHANGE; PREGNANCY; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 33747457056     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-006-0018-y     Document Type: Review

References (88)

1. Adams K. M., Lambert N. C., Heimfeld S., Tylee T. S., Pang J. M., Erickson T. D. and Nelson J. L. (2003): Male DNA in female donor apheresis and CD34-enriched prod-ucts. Blood, 102, 3845-3847.
2. Aluvihare V. R., Kallikourdis M. and Betz A.G. (2004): Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol., 5, 266-271.
3. Andrassy J., Kusaka S., Jankowska-Gan E., Torrealba J. R., Haynes L. D., Marthaler B. R., Tam R. C., Illigens B. M., Anosova N., Benichou G. and Burlingham W. J. (2003): Tolerance to noninherited maternal MHC antigens in mice. J. Immunol., 171, 5554-5561.
4. Artlett C. M., Smith J. B. and Jimenez S. A. (1998): Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N. Engl. J. Med., 338, 1186-1191.
5. Aversa F., Tabilio A., Terenzi A., Velardi A., Falzetti F., Giannoni C., Iacucci R., Zei T., Martelli M. P., Gambelunghe C., Rossetti M., Caputo P., Latini P., Aristei C., Raymondi C., Reisner Y. and Martelli M. F. (1994): Successful engraftment of T-cell depleted haploidentical "three-loci" incompatible transplants in leukaemia patients by addition of recombinant human G-CSF mobilised peripheral blood progenitor cells to bone marrow inoculum. Blood, 84, 3948-3955.
6. Beatty P. G., Clift R. A., Mickelson E. M., Nisperos B. B., Flournoy N., Martin P. J., Sanders J. E., Stewart P., Buckner C. D. and Storb R. (1985): Marrow transplantation from related donors other than HLA-identical siblings. N. Engl. J. Med., 313, 765-771.
7. Billingham R. E., Brent L. and Medawar P. B. (1953): Actively acquired tolerance of foreign cells. Nature, 172, 603-606.
8. Blaha P., Bigenzahn S., Koporc Z., Schmid M., Langer F., Selzer E., Bergmeister H., Wrba F., Kurtz J., Kiss C., Roth E., Muehlbacher F., Sykes M. and Wekerle T. (2003): The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood, 101, 2886-2893.
9. Brune T., Riepe F. G., Garritsen H., Exeler R., Louwen F. and Harms E. (2003): The cellular immune response of children is specifically decreased against their parents but not vice versa, independent of pregnancy, age, or HLA or HY antigens. Am. J. Reprod. Immunol., 49, 255-260.
10. Burlingham W. J., Grailer A. P., Fechner J. H, Jr., Kusaka S., Trucco M., Kocova M., Belzer F. O. and Sollinger H. W. (1995): Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation, 59, 1147-1155.
11. Burt R. K., Traynor A., Oyama Y. and Craig R. (2003): High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease. Blood, 101, 2064-2066.
12. Campbell D. A. Jr., Lorber M. I., Sweeton J. C., Turcotte J. G., Niederhuber J. E. and Beer A. E. (1984): Breast feeding and maternal-donor renal allografts. Possibly the original donor-specific transfusion. Transplantation, 37, 340-344.
13. Childs R., Chernoff A., Contentin N., Bahceci E., Schrump D., Leitman S., Read E. J., Tisdale J., Dunbar C., Linehan W. M., Young N. S. and Barrett A. J. (2000): Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N. Engl. J. Med., 343, 750-758.
14. Claas F. (2004): Chimerism as a tool to induce clinical transplantation tolerance. Curr. Opin. Immunol., 16, 578-583.
15. Darasse-Jeze G., Klatzmann D., Charlotte F., Salomon B. L. and Cohen J. L. (2006): CD4(+)CD25(+) regulatory/suppressor T cells prevent allogeneic fetus rejection in mice. Immunol. Lett., 102, 106-109.
16. Edinger M., Hoffmann P., Ermann J., Drago K., Fathman C. G., Strober S. and Negrin R. S. (2003): CD4(+)CD25(+) regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat. Med., 9, 1144-1150.
17. Eto M., Kong Y. Y., Uozumi J., Naito S. and Nomoto K. (1999): Importance of Intrathymic mixed chimerism for the maintenance of skin allograft tolerance across fully allogeneic antigens in mice. Immunology, 96, 440-446.
18. Field E. H., Matesic D., Rigby S., Fehr T., Rouse T. and Gao Q. (2001): CD4+CD25+ regulatory cells in acquired MHC tolerance. Immunol. Rev., 182, 99-112.
19. Fournel S., Aguerre-Girr M., Hue X., Lenfant F., Alam A., Toubert A., Bensussan A. and Le Bouteiller P. (2000): Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J. Immunol., 164, 6100-6104.
20. Gratwohl A., Brand R., Apperley J., Biezen Av A., Bandini G., Devergie A., Schattenberg A., Frassoni F., Guglielmi C., Iacobelli S., Michallet M., Kolb H. J., Ruutu T. and Niederwieser D. (2002): Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood, 100, 3877-3886.
21. Guleria I., Khosroshahi A., Ansari M. J., Habicht A., Azuma M., Yagita H., Noelle R. J., Coyle A., Mellor A. L., Khoury S. J. and Sayegh M. H. (2005): A critical role for the programmed death ligand 1 in fetomaternal tolerance. J. Exp. Med., 202, 231-237.
22. Hall J. M., Lingenfelter P., Adams S. L., Lasser D., Hansen J. A. and Bean M. A. (1995): Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization. Blood, 86, 2829-2832.
23. Hisanaga M., Hundrieser J., Boker K., Uthoff K., Raddatz G., Wahlers T., Wonigeit K., Pichlmayr R. and Schlitt H. J. (1996): Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation. Transplantation, 61, 40-45.
24. Horowitz M. M., Gale R. P., Sondel P. M., Goldman J. M., Kersey J., Kolb H. J., Rimm A. A., Ringden O., Rozman C. and Speck B. (1990): Graft-versus-leukemia reactions after bone marrow transplantation. Blood, 75, 555-562.
25. Hunt J. S., Vassmer D., Ferguson T. A. and Miller L. (1997): Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J. Immunol., 158, 4122-4128.
26. Ichinohe T., Teshima T., Matsuoka K., Maruya E. and Saji H. (2005): Fetal-maternal microchimerism: Impact on hematopoietic stem cell transplantation. Curr. Opin. Immunol., 17, 546-552.
27. Ichinohe T., Uchiyama T., Shimazaki C., Matsuo K., Tamaki S., Hino M., Watanabe A., Hamaguchi M., Adachi S., Gondo H., Uoshima N., Yoshihara T., Hatanaka K., Fujii H., Kawa K., Kawanishi K., Oka K., Kimura H., Itoh M., Inukai T., Maruya E., Saji H. and Kodera Y. (2004): Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism. Blood, 104, 3821-3828.
28. Ilan Y., Gotsman I., Pines M., Beinart R., Zeira M., Ohana M., Rabbani E., Engelhardt D. and Nagler A. (2000): Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model. Blood, 95, 3613-3619.
29. James E., Chai J. G., Dewchand H., Macchiarulo E., Dazzi F. and Simpson E. (2003): Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans. Blood, 102, 388-393.
30. Jimenez S. A. and Artlett C. M. (2005): Microchimerism and systemic sclerosis. Curr. Opin. Rheumatol., 17, 86-90.
31. Kanamoto A., Monaco A. P. and Maki T. (2004): Active role of chimerism in transplantation tolerance induced by antilymphocyte serum, sirolimus, and bone-marrow-cell infusion. Transplantation, 78, 825-830.
32. Karim M., Kingsley C. I., Bushell A. R., Sawitzki B. S. and Wood K. J. (2004): Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process. J. Immunol., 172, 923-938.
33. Khosrotehrani K. and Bianchi D. W. (2005): Multi-lineage potential of fetal cells in maternal tissue: A legacy in reverse. J. Cell Sci., 118, 1559-1563.
34. Khosrotehrani K., Johnson K. L., Guegan S., Stroh H. and Bianchi D. W. (2005): Natural history of fetal cell microchimerism during and following murine pregnancy. J. Reprod. Immunol., 66, 1-12.
35. Khosrotehrani K., Mery L., Aractingi S., Bianchi D. W. and Johnson K. L. (2005): Absence of fetal cell microchimerism in cutaneous lesions of lupus erythematosus. Ann. Rheum. Dis., 64, 159-160.
36. Khosrotehrani K., Wataganara T., Bianchi D. W. and Johnson K. L. (2004): Fetal cell-free DNA circulates in the plasma of pregnant mice: Relevance for animal models of fetomaternal trafficking. Hum. Reprod., 19, 2460-2464.
37. Ko S., Deiwick A., Jager M. D., Dinkel A., Rohde F., Fischer R., Tsui T. Y., Rittmann K. L., Wonigeit K. and Schlitt H. J. (1999): The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat. Nat. Med., 5, 1292-1297.
38. Matsuoka K., Ichinohe T., Hashimoto D., Asakura S., Tanimoto M. and Teshima T. (2006): Fetal tolerance to maternal antigens improves the outcome of allogeneic bone marrow transplantation by a CD4+CD25+ T-cell-dependent mechanism. Blood, 107, 404-409.
39. McSweeney P. A., Niederwieser D., Shizuru J. A., Sandmaier B. M., Molina A. J., Maloney D. G., Chauncey T. R., Gooley T. A., Hegenbart U., Nash R. A., Radich J., Wagner J. L., Minor S., Appelbaum F. R., Bensinger W. I., Bryant E., Flowers M. E., Georges G. E., Grumet F. C., Kiem H. P., Torok-Storb B., Yu C., Blume K. G. and Storb R. F. (2001): Hematopoietic cell transplantation in older patients with hematologic malignancies: Replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood, 97, 3390-3400.
40. Mellor A. L., Sivakumar J., Chandler P., Smith K., Molina H., Mao D. and Munn D. H. (2001): Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat. Immunol., 2, 64-68.
41. Molitor M. L., Haynes L. D., Jankowska-Gan E., Mulder A. and Burlingham W. J. (2004): HLA class I noninherited maternal antigens in cord blood and breast milk. Hum. Immunol., 65, 231-239.
42. Munn D. H., Zhou M., Attwood J. T., Bondarev I., Conway S. J., Marshall B., Brown C. and Mellor A. L. (1998): Prevention of allogeneic fetal rejection by tryptophan catabolism. Science, 281, 1191-1193.
43. Murata H., Nakauchi H. and Sumida T. (1999): Microchimerism in Japanese women patients with systemic sclerosis. Lancet, 354, 220.
44. Nelson J. L. (2003): Microchimerism in human health and disease. Autoimmunity, 36, 5-9.
45. Nelson J. L., Furst D. E., Maloney S., Gooley T., Evans P. C., Smith A., Bean M. A., Ober C. and Bianchi D. W. (1998). Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet, 351, 559-562.
46. Nishimura E., Sakihama T., Setoguchi R., Tanaka K. and Sakaguchi S. (2004): Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising foxp3+CD25+CD4+ regulatory T cells. Int. Immunol., 16, 1189-1201.
47. Noris M., Cugini D., Casiraghi F., Azzollini N., De Deus Viera Moraes L., Mister M., Pezzotta A., Cavinato R. A., Aiello S., Perico N. and Remuzzi G. (2001): Thymic microchimerism correlates with the outcome of tolerance-inducing protocols for solid organ transplantation. J. Am. Soc. Nephrol., 12, 2815-2826.
48. O'Donoghue K., Chan J., de la Fuente J., Kennea N., Sandison A., Anderson J. R., Roberts I. A. and Fisk N. M. (2004): Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet, 364, 179-182.
49. Obama K., Utsunomiya A., Takatsuka Y. and Takemoto Y. (2004): Reduced-intensity non-T-cell depleted HLA-haploidentical stem cell transplantation for older patients based on the concept of feto-maternal tolerance. Bone Marrow Transplant., 34, 897-899.
50. Ochiai N., Shimazaki C., Fuchida S., Okano A., Sumikuma T., Ashihara E., Inaba T., Fujita N., Maruya E. and Nakagawa M. (2002): Successful non-T cell-depleted HLA haplo-identical three-loci mismatched hematopoietic stem cell transplantation from mother to son based on the feto-maternal microchimerism in chronic myelogenous leukemia. Bone Marrow Transplant., 30, 793-796.
51. Owen R. D. (1945): Immunogenetic consequences of vascular anastomoses between bovine twins. Science, 102, 400-401.
52. Phillips T. A., Ni J., Pan G., Ruben S. M., Wei Y. F., Pace J. L. and Hunt J. S. (1999): TRAIL (apo-21) and TRAIL receptors in human placentas: Implications for immune privilege. J. Immunol., 162, 6053-6059.
53. Reddy P., Maeda Y., Liu C., Krijanovski O. I., Korngold R. and Ferrara J. L. (2005): A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat. Med., 11, 1244-1249.
54. Rouas-Freiss N., Goncalves R. M., Menier C., Dausset J., and Carosella E. D. (1997): Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc. Natl. Acad. Sci. USA, 94, 11520-11525.
55. Sanchez-Fueyo A., Sandner S., Habicht A., Mariat C., Kenny J., Degauque N., Zheng X. X., Strom T. B., Turka L. A. and Sayegh M. H. (2006): Specificity of CD4+CD25+ regulatory T cell function in alloimmunity. J. Immunol., 176, 329-334.
56. Satoh M., Miyamura K., Yamada M., Ishidoya S., Childs R. W. and Arai Y. (2004): Haploidentical, non-myeloablative stem-cell transplantation for advanced renal-cell carcinoma. Lancet Oncol., 5, 125-126.
57. Shimamura M. Ohta S., Suzuki R. and Yamazaki K.. (1994): Transmission of maternal blood cells to the fetus during pregnancy: Detection in mouse neonatal spleen by immunofluorescence flow cytometry and polymerase chain reaction. Blood, 83, 926-930.
58. Shimazaki C., Ochiai N., Uchida R., Okano A., Fuchida S., Ashihara E., Inaba T., Fujita N., Maruya E. and Nakagawa M. (2003): Non-T-cell-depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies Based on the feto-maternal michrochimerism. Blood, 101, 3334-3336.
59. Shlomchik W. D., Couzens M. S., Tang C. B., McNiff J., Robert M. E., Liu J., Shlomchik M. J. and Emerson S. G. (1999): Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science, 285, 412-415.
60. Sorror M. L., Maris M. B., Storer B., Sandmaier B. M., Diaconescu R., Flowers C., Maloney D. G. and Storb R. (2004): Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: Influence of pretransplantation comorbidities. Blood, 104, 961-968.
61. Srivatsa B., Srivatsa S., Johnson K. L. and Bianchi D. W. (2003): Maternal cell microchimerism in newborn tissues. J. Pediatr., 142, 31-35.
62. Srivatsa B., Srivatsa S., Johnson K. L., Samura O., Lee S. L. and Bianchi D. W. (2001): Microchimerism of presumed fetal origin in thyroid specimens from women: A case-control study. Lancet, 358, 2034-2038.
63. Starzl T. E., Demetris A. J., Murase N., Ildstad S., Ricordi C. and Trucco M. (1992): Cell migration, chimerism, and graft acceptance. Lancet, 339, 1579-1582.
64. Suskind D. L., Rosenthal P., Heyman M. B., Kong D., Magrane G., Baxter-Lowe L. A. and Muench M. O. (2004): Maternal microchimerism in the livers of patients with biliary atresia. BMC Gastroenterol., 4, 14.
65. Sykes M., Preffer F., McAfee S., Saidman S. L., Weymouth D., Andrews D. M., Colby C., Sackstein R., Sachs D. H. and Spitzer T. R. (1999): Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation. Lancet, 353, 1755-1759.
66. Tafuri A., Alferink J., Moller P., Hammerling G. J. and Arnold B. (1995): T cell awareness of paternal alloantigens during pregnancy. Science, 270, 630-633.
67. Teshima T., Hill G. R., Pan L., Brinson Y. S., van den Brink M. R., Cooke K. R. and Ferrara J. L. (1999): IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation. J. Clin. Invest., 104, 317-325.
68. Teshima T., Ordemann R., Reddy P., Gagin S., Liu C., Cooke K. R. and Ferrara J. L. (2002): Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat. Med., 8, 575-581.
69. Tokita K., Terasaki P., Maruya E. and Saji H. (2001): Tumour regression following stem cell infusion from daughter to microchimeric mother. Lancet, 358, 2047-2048.
70. Trenado A., Charlotte F., Fisson S., Yagello M., Klatzmann D., Salomon B. L. and Cohen J. L. (2003): Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J. Clin. Invest., 112, 1688-1696.
71. Tsafrir A., Brautbar C., Nagler A., Elchalal U., Miller K. and Bishara A. (2000): Alloreactivity of umbilical cord blood mononuclear cells: Specific hyporesponse to noninherited maternal antigens. Hum. Immunol., 61, 548-554.
72. Tsutsumi Y., Tanaka J., Miura T., Saitoh S., Yamada M., Yamato H., Ehira N., Kanamori H., Kawamura T., Obara S., Ogura N., Matsushima T., Maruya E., Asaka M., Imamura M., Saji H. and Masauzi N. (2004): Successful non-T-cell-depleted nonmyeloablative hematopoietic stem cell transplantation (NST) from an HLA-haploidentical 2-loci-mismatched sibling in a heavily transfused patient with severe aplastic anemia based on the fetomaternal microchimerism. Bone Marrow Transplant., 34, 267-269.
73. Vacchio M. S. and Hodes R. J. (2005): Fetal expression of Fas ligand is necessary and sufficient for induction of CD8 T cell tolerance to the fetal antigen H-Y during pregnancy. J. Immunol., 174, 4657-4661.
74. van Kampen C. A., Versteeg-van der Voort Maarschalk M. F., Langerak-Langerak J., van Beelen E., Roelen D. L. and Claas F. H. (2001): Pregnancy can induce long-persisting primed CTLs specific for inherited paternal HLA antigens. Hum. Immunol., 62, 201-207.
75. van Rood J. J., Loberiza, Jr. F. R., Zhang M. J., Oudshoorn M., Claas F., Cairo M. S., Champlin R. E., Gale R. P., Ringden O., Hows J. M. and Horowitz M. H. (2002): Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood, 99, 1572-1577.
76. Verdijk R. M., Kloosterman A., Pool J., van de Keur M., Naipal A. M., van Halteren A. G., Brand A., Mutis T. and Goulmy E. (2004): Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: Implications for stem cell transplantation and immunotherapy. Blood, 103, 1961-1964.
77. Vernochet C., Caucheteux S. M., Gendron M. C., Wantyghem J. and Kanellopoulos-Langevin C. (2005): Affinity-dependent alterations of mouse B cell development by noninherited maternal antigen. Biol. Reprod., 72, 460-469.
78. Wan W., Shimizu S., Ikawa H., Sugiyama K. and Yamaguchi N. (2002): Maternal cell traffic bounds for immune modulation: Tracking maternal H-2 alleles in spleens of baby mice by DNA fingerprinting. Immunology, 107, 261-267.
79. Wang Y., Iwatani H., Ito T., Horimoto N., Yamato M., Matsui I., Imai E. and Hori M. (2004): Fetal cells in mother rats contribute to the remodeling of liver and kidney after injury. Biochem. Biophys. Res. Commun., 325, 961-967.
80. Weiden P., Flournoy N. and Thomas E. D. (1979): Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N. Engl. J. Med., 300, 1068-1073.
81. Weiden P. L., Sullivan K. M., Flournoy N., Storb R. and Thomas E. D. (1981): Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation. N. Engl. J. Med., 304, 1529-1533.
82. Wood K. and Sachs D. H. (1996): Chimerism and transplantation tolerance: Cause and effect. Immunol. Today, 17, 584-587.
83. Xu C., Mao D., Holers V. M., Palanca B., Cheng A. M. and Molina H. (2000): A critical role for murine complement regulator crry in fetomaternal tolerance. Science, 287, 498-501.
84. Yabe H., Inoue H., Matsumoto M., Hamanoue S., Hiroi A., Koike T., Sako M., Fujiwara M., Ueda Y., Maruya E., Saji H., Kato S. and Yabe M. (2004): Unmanipulated HLA-haploidentical bone marrow transplantation for the treatment of fatal, nonmalignant diseases in children and adolescents. Int. J. Hematol., 80, 78-82.
85. Yoshihara T., Morimoto A., Inukai T., Kuroda H., Ishida H., Sugita K., Goi K., Imamura T., Todo S., Maruya E., Saji H., Nakazawa S. and Imashuku S. (2004): Non-T-cell-depleted HLA haploidentical stem cell transplantation based on feto-maternal microchimerism in pediatric patients with advanced malignancies. Bone Marrow Transplant., 34, 373-375.
86. Zhang H., Chua K. S., Guimond M., Kapoor V., Brown M. V., Fleisher T. A., Long L. M., Bernstein D., Hill B. J., Douek D. C., Berzofsky J. A., Carter C. S., Read E. J., Helman L. J. and Mackall C. L. (2005): Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat. Med., 11, 1238-1243.
87. Zhang L. and Miller R. G. (1993): The correlation of prolonged survival of maternal skin grafts with the presence of naturally transferred maternal T cells. Transplantation, 56, 918-921.
88. Zhang Y., Louboutin J. P., Zhu J., Rivera A. J. and Emerson S. G. (2002): Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. J. Clin. Invest., 109, 1335-1344.